Vimarsana
Biggest News Aggregation in the World

Page 2 - Core One News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Core One. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Core One Today - Breaking & Trending Today

OTC Hearing Aids Ceretone Bags over $300,000 on Indiegogo, Prepares for Official Sale - Vimarsana News

OTC Hearing Aids Ceretone Bags over $300,000 on Indiegogo, Prepares for Official Sale

/PRNewswire/ -- Ceretone, a brand under Audicon and a pioneer in the field of Over-the-Counter (OTC) hearing aids, is thrilled to announce the success of its...

Core One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer's and Parkinson's Disease Seite 1 - Vimarsana News

Core One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer's and Parkinson's Disease Seite 1

05.08.2023 - VANCOUVER, BC / ACCESSWIRE / August 4, 2023 / Core One Labs Inc. (CSE:COOL) (OTCQB:CLABF) (Frankfurt:LD6, WKN:A3CSSU), (the 'Company' or 'Core One') is delighted to announce the receipt of additional positive results from its second round ('Round ... Seite 1

Core One's Akome Reveals Groundbreaking Positive Results from its Second ... - Vimarsana News

Core One's Akome Reveals Groundbreaking Positive Results from its Second ...

Core One's Akome Reveals Groundbreaking Positive Results from its Second ...

Core One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer's and Parkinson's Disease - Core One Labs (OTC:CLABF) - Vimarsana News

Core One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer's and Parkinson's Disease - Core One Labs (OTC:CLABF)

VANCOUVER, BC / ACCESSWIRE / July 28, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6) (WKN:A3CSSU) (the "Company" or "Core One"), is excited to share positive results from its first

Core One Labs Enters into Letter of Intent for First Sale of Its Psychedelic ... - Vimarsana News

Core One Labs Enters into Letter of Intent for First Sale of Its Psychedelic ...

Core One Labs Enters into Letter of Intent for First Sale of Its Psychedelic ...